National Academies, Sunnylands, and APPC Retreats on the Integrity of Science

Friday, August 7, 2020

Topics: 02_NAS/NAM: Ethics, Equity, and Emerging Technologies, 02_NAS/NAM: Summit on Human Genome Editing, 08_NAS: Protecting Science in the Courts, Civic Engagement, Retreat News, Science

Date: February 1, 2015 - November 29, 2019

In 2015, The Annenberg Foundation Trust at Sunnylands, the Annenberg Public Policy Center, and the National Academy of Sciences (NAS) began working together to fulfill Sunnylands’ mission to host “meetings of leaders and specialists in the major medical and scientific associations and institutions for the purpose of promoting and facilitating the exchange of ideas … to make advancements … for the common good and the public interest.”

During the first five years (2015-2020), these partner organizations, joined by the National Academies of Sciences, Engineering, and Medicine (NASEM), have convened eight Sunnylands retreats. At these convenings, leaders in science, academia, business, medical ethics, the judiciary and the bar, government, and scientific publishing explored ways to increase the integrity of science; articulate the ethical principles that should guide scientific practice to ensure that science works at the frontiers of human knowledge in an ethical way; and protect the courts from inadvertent as well as deliberate misstatements about scientific knowledge.

Please see the Annenberg Public Policy Center website for an overview of these eight retreats and their outcomes.

CEOs and Leaders for Science Retreat photos

The CEOs and Leaders for Science retreat at Sunnylands, with (clockwise from bottom left) Kathleen Hall Jamieson, director of the Annenberg Public Policy Center; Charlie Munger, vice chairman of Berkshire Hathaway; TIAA CEO Roger W. Ferguson Jr.; Chevron CEO John S. Watson; Wanda Austin, president and CEO, Aerospace Corp.; Norman R. Augustine, former CEO, Lockheed Martin Corp.; Carol Folt, president of the University of Southern California; James L. Green, NASA chief scientist; Amgen CEO Robert Bradway; and Subra Suresh, former president, Carnegie Mellon University.